To initiate a project and take it all the way to a successful exit requires an organization with the right people in the right positions at the right time.
Trophea is organized to represent all the necessary skills and competences of an innovative and successful biotech company. The company is run as a virtual organization with project management, financing, accounting and administrative support being provided by PULS, www.pulsinvest.se.
Trophea has a highly dedicated and experienced management team and board which are key to the project development. Furthermore, Trophea has active collaborations with the innovators and professional networks, providing the company with world class scientific input.
In addition, Trophea has access to PULS’s extensive partner network. Learn more, www.pulsinvest.se/people/partners/.
Mats Lidgard, Chairman of the Board
LL.M, Senior Partner in the human venture capital company Lavindia AB. Former international experiences from i.a. the Pharmacia Group, Active Biotech AB and SBL Vaccin AB as general counsel and various other executive management positions. Board member of Adenovir Pharma AB, Scandinavian Biopharma Holding AB, Synphora AB and Lavindia AB.
Anna Törner, Board member
Managing Director of SDS, a Swedish consultancy focused on drug development and biostatistics. Experienced in regulatory affairs and biostatistics from work within regulatory authorities, the pharmaceutical industry and academic research. Main expert area is clinical development and design of clinical trials. MSc (Pharm) and MSc (Math Stat), PhD Medical Science Karolinska.
Jan Faergemann, Board member
MD, PhD, Professor in Dermatology at Sahlgrenska Academy, University of Gothenburg. World leading researcher in dermatology with a special interest in Mycology and Dermato-Pharmacology. Innovator and former board member of Ambria Dermatology AB and innovator in Trophea AB.
Göran Kvist, Board member
M.Sc. (Pharm.), University of Uppsala. CEO of GMP consulting company, TQ Kvalitetskonsult AB. Licensed Qualified Person with focus on quality systems and auditing according to cGMP in EU, US and Asia. Board member of AcuCort AB and Trophea AB. Co-founder and board member of QP Support AB. Co-founder of Dilafor AB.
Gudmundur Johannsson, Board member
MD, PhD, Professor of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Senior consultant Department of Endocrinology, Sahlgrenska University Hospital. Editor of the European Journal of Endocrinology, president of the Growth Hormone Research Society. Board member of Trophea AB. Innovator of AcuCort AB, DuoCort Pharma AB and Trophea AB.
Jeanette Robertsson, CEO
PhD, M.Sc. in Pharm. followed by post-doc studies in the U.S. She has gained broad experience from key international positions as medical director, project management of drug development and head of clinical trials in the pharma industry; Novartis, Perstorp Pharma, Searle Scandinavia, Tigran Technologies and CDC. Currently project leader of Laccure AB, Trophea AB and Belina Pharma AB. Board member of Glactone Pharma AB.
Jan Faergemann, Main innovator
MD, PhD, Professor in Dermatology at Sahlgrenska Academy, University of Gothenburg. World leading researcher in dermatology with a special interest in Mycology and Dermato-Pharmacology. Innovator and former board member of Ambria Dermatology AB and Main innovator in Trophea AB.
Gudmundur Johannsson, Innovator
MD, PhD, Professor of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Senior consultant Department of Endocrinology, Sahlgrenska University Hospital. Editor of the European Journal of Endocrinology, president of the Growth Hormone Research Society. Board member of Trophea AB. Innovator in AcuCort AB, DuoCort Pharma AB and Trophea AB.
Jörgen Johnsson, Innovator
Former CEO of Pharmacia Consumer Healthcare worldwide, Senior Vice President of Pharmacia Corporation and member of Pharmacia’s Executive Management Group from 1995-2000. Founder of P.U.L.S. AB, PULS partner and board member of Laccure AB. Innovator in multiple PULS project companies.
Claes Ohlsson, Innovator
MD, PhD, Professor at the Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg. Internationally recognized and award winning researcher in metabolic bone diseases and innovator in Trophea AB. Former chairman of P.U.L.S. AB.
Jan Törnell, Innovator
MD, PhD, CEO of Oncorena. Former global Vice President Strategy, AstraZeneca Oncology & Infection. Professor, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg. CEO of Innoext AB. Board Director of Diaprost AB and Stayble Therapeutics AB. Chairman of Glactone Pharma AB and LIDDS AB. Innovator in Trophea AB.
Greg Batcheller, InnovatorB.Sc. (Econ), J.D, LL.M. Chairman of Xintela AB, Monocl AB, Saga Diagnostics AB and ImmuneBiotech Medical AB. Partner of Business Research Life Sciences Ltd. Advisor to pharmaceutical, biotech, medical device and other high technology companies. Former project leader of DuoCort AB and AcuCort AB. Innovator in Laccure AB and Trophea AB.